Sub-mucosal agent delivery, apparatus, system and method

• US 8,652,118 B2
• Filed: 02/10/2011
• Issued: 02/18/2014
• Est. Priority Date: 04/08/2010
• Status: Active Grant

• Current Assignee: KMG Pharma, LLC
• Original Assignee: KMG Pharma, LLC
• Inventors: Peyman, Gholam A.
• Primary Examiner(s): Mehta, Bhisma
• Assistant Examiner(s): OSINSKI, BRADLEY JAMES
• Application Number:
  US12/931,834
• Publication Number:
  US 20110251585A1
• Time in Patent Office: 1,104 Days
• Field of Search: 604/116, 604/506, 604/521, 604/289, 604/290, 604294-302
• US Class Current: 604/521
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61M 5/30 Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules

Abstract

An agent delivery apparatus for administering a pharmacological agent formulation to a sub-mucosal compartment of a body organ, comprising injector means having an internal formulation chamber that is adapted to receive and contain the pharmacological agent formulation therein and an elongated agent delivery member having a first end that is in communication with the internal formulation chamber and a second ejection end, the injector means including force generating means that is adapted to generate sufficient force to expel the pharmacological agent formulation from the injector means and into and through the agent delivery member, and out of the ejection end of the elongated agent delivery member. In one embodiment of the invention, the delivery member comprises a needleless delivery member.

Claims

1. A method for administering a pharmacological agent formulation to a sub-mucosal compartment of an organ, comprising the steps of (i) providing a needleless agent delivery apparatus containing the pharmacological agent formulation in an internal formulation chamber, said agent delivery apparatus including an elongated agent delivery member, said agent delivery member including an integral nozzle member-positioning hood assembly, said nozzle member-positioning hood assembly comprising a first nozzle member and a deformable positioning hood that is adapted to substantially conform to the surface of an organ and position said agent delivery member on said organ when in an engagement position thereon, and force generating means that is adapted to generate sufficient force to expel the pharmacological agent formulation from said agent delivery apparatus and into an organ, (ii) positioning said agent delivery apparatus on a surface of a first organ, and (iii) activating the agent delivery apparatus, whereby the pharmacological agent formulation is expelled from the agent delivery apparatus by said force generating means and delivered to the surface of said first organ with a delivery pressure in the range of approximately 100-1000 psi and, whereby a first volume of the pharmacological agent formulation is administered to a sub-mucosal compartment of said first organ.

2. The method of claim 1, wherein said first volume of the pharmacological agent formulation administered to said sub-mucosal compartment of said first organ is in the range of approximately 0.025-1 ml.

3. The method of claim 1, wherein said first organ comprises the eye.

4. The method of claim 1, wherein said first organ comprises an organ selected from the group consisting of the nose, mouth, throat, trachea, esophagus, stomach, urethra, bladder and vagina.

5. The method of claim 1, wherein said agent delivery member includes suction means that provides an eye engagement force and seals said agent delivery member to said first organ when said delivery member is in said engagement position.